• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫浆液性癌:评估基因组学与转移模式之间的关联

Uterine serous carcinoma: assessing association between genomics and patterns of metastasis.

作者信息

Alessandrino Francesco, Goncalves Nicole, Metalonis Sarah Wishnek, Luna Cibele, Mason Matthew M, Lyu Jiangnan, Huang Marilyn

机构信息

Department of Radiology, University of Miami, Miami, FL, United States.

University of Miami Miller School of Medicine, Miami, FL, United States.

出版信息

Front Oncol. 2023 May 9;13:1066427. doi: 10.3389/fonc.2023.1066427. eCollection 2023.

DOI:10.3389/fonc.2023.1066427
PMID:37228503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10203475/
Abstract

BACKGROUND

Uterine serous carcinoma (USC) is an aggressive subtype of endometrial carcinoma which has been increasing at alarming rates, particularly among Asian, Hispanic and Black women. USC has not been well characterized in terms of mutational status, pattern of metastases and survival.

OBJECTIVE

To investigate the association between sites of recurrence and metastases of USC, mutational status, race, and overall survival (OS).

METHODS

This single-center retrospective study evaluated patients with biopsy-proven USC that underwent genomic testing between January 2015 and July 2021. Association between genomic profile and sites of metastases or recurrence was performed using χ2 or Fisher's exact test. Survival curves for ethnicity and race, mutations, sites of metastasis/recurrence were estimated using the Kaplan-Meier method and compared with log-rank test. Cox proportional hazard regression models were used to examine the association between OS with age, race, ethnicity, mutational status, and sites of metastasis/recurrence. Statistical analyses were performed using SAS Software Version 9.4.

RESULTS

The study included 67 women (mean age 65.8 years, range 44-82) with 52 non-Hispanic women (78%) and 33 Black women (49%). The most common mutation was (55/58 women, 95%). The peritoneum was the most common site of metastasis (29/33, 88%) and recurrence (8/27, 30%). PR expression was more common in women with nodal metastases (p=0.02) and non-Hispanic women (p=0.01). alterations were more common in women with vaginal cuff recurrence (p=0.02), while mutation was more common in women with liver metastases (p=0.048). mutation and presence of recurrence or metastases to the liver were associated with lower OS (Hazard Ratio (HR): 31.87; 95%CI: 3.21, 316.9; p<0.001 and HR: 5.66; 95%CI: 1.2, 26.79; p=0.01, respectively). In the bivariable Cox model, the presence of metastasis/recurrence to the liver and/or the peritoneum were both independent significant predictors of OS (HR: 9.8; 95%CI: 1.85-52.7; p=0.007 and HR: 2.7; 95%CI: 1.02-7.1; p=0.04, respectively).

CONCLUSIONS

is often mutated in USC, which most commonly metastasize and recur in the peritoneum. OS was shorter in women with mutations and with metastasis/recurrence to the liver. The presence of metastasis/recurrence to liver and/or peritoneum were independently associated with shorter OS.

摘要

背景

子宫浆液性癌(USC)是子宫内膜癌的一种侵袭性亚型,其发病率正以惊人的速度上升,尤其是在亚洲、西班牙裔和黑人女性中。USC在突变状态、转移模式和生存率方面尚未得到充分的特征描述。

目的

研究USC复发和转移部位、突变状态、种族与总生存期(OS)之间的关联。

方法

这项单中心回顾性研究评估了2015年1月至2021年7月期间接受基因检测且活检证实为USC的患者。使用χ2检验或Fisher精确检验分析基因谱与转移或复发部位之间的关联。采用Kaplan-Meier方法估计种族、突变、转移/复发部位的生存曲线,并通过对数秩检验进行比较。使用Cox比例风险回归模型检验OS与年龄、种族、民族、突变状态以及转移/复发部位之间的关联。使用SAS软件9.4版进行统计分析。

结果

该研究纳入了67名女性(平均年龄65.8岁,范围44-82岁),其中52名非西班牙裔女性(78%)和33名黑人女性(49%)。最常见的突变是(55/58名女性,95%)。腹膜是最常见的转移部位(29/33,88%)和复发部位(8/27,30%)。PR表达在有淋巴结转移的女性(p=0.02)和非西班牙裔女性(p=0.01)中更常见。改变在阴道断端复发的女性中更常见(p=0.02),而突变在有肝转移的女性中更常见(p=0.048)。突变以及肝转移或复发与较低的OS相关(风险比(HR):31.87;95%置信区间:3.21,316.9;p<0.001和HR:5.66;95%置信区间:1.2,26.79;p=0.01)。在双变量Cox模型中,肝和/或腹膜转移/复发的存在均是OS的独立显著预测因素(HR:9.8;95%置信区间:1.85-52.7;p=0.007和HR:2.7;95%置信区间:1.02-7.1;p=0.04)。

结论

在USC中常发生突变,其最常见的转移和复发部位是在腹膜。有突变以及肝转移/复发的女性OS较短。肝和/或腹膜转移/复发的存在与较短的OS独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b678/10203475/d45a2381e5f7/fonc-13-1066427-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b678/10203475/72806d050bd6/fonc-13-1066427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b678/10203475/95de5d9aee74/fonc-13-1066427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b678/10203475/d45a2381e5f7/fonc-13-1066427-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b678/10203475/72806d050bd6/fonc-13-1066427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b678/10203475/95de5d9aee74/fonc-13-1066427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b678/10203475/d45a2381e5f7/fonc-13-1066427-g003.jpg

相似文献

1
Uterine serous carcinoma: assessing association between genomics and patterns of metastasis.子宫浆液性癌:评估基因组学与转移模式之间的关联
Front Oncol. 2023 May 9;13:1066427. doi: 10.3389/fonc.2023.1066427. eCollection 2023.
2
Endometrial carcinoma: association between mutational status, sites of metastasis, recurrence, and correlation with overall survival.子宫内膜癌:突变状态、转移部位、复发之间的关联以及与总生存期的相关性
Abdom Radiol (NY). 2023 Aug;48(8):2684-2694. doi: 10.1007/s00261-023-03973-3. Epub 2023 Jun 8.
3
Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.肌肉浸润性尿路上皮癌:突变状态与转移模式和生存的关系。
Radiology. 2020 Jun;295(3):572-580. doi: 10.1148/radiol.2020191770. Epub 2020 Mar 31.
4
Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?子宫浆液性癌和3级子宫内膜样癌:生存率有差异吗?
Cancer. 2004 Nov 15;101(10):2214-21. doi: 10.1002/cncr.20645.
5
The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases.单纯子宫浆液性癌与含浆液性成分的混合瘤的比较:单机构 91 例回顾性研究。
BMC Cancer. 2024 Jan 17;24(1):99. doi: 10.1186/s12885-023-11793-3.
6
Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency testing in uterine serous carcinoma.比较子宫浆液性和高级别浆液性卵巢癌中同源重组基因的突变频率:在子宫浆液性癌中进行同源重组缺陷检测的理由。
Gynecol Oncol. 2020 Nov;159(2):381-386. doi: 10.1016/j.ygyno.2020.08.012. Epub 2020 Sep 6.
7
Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma.淋巴结切除术对手术治疗的明显早期子宫浆液性癌患者生存的影响。
J Gynecol Oncol. 2020 Sep;31(5):e64. doi: 10.3802/jgo.2020.31.e64.
8
The role of omentectomy in the surgical treatment of uterine serous carcinoma.网膜切除术在子宫浆液性癌手术治疗中的作用。
Eur J Obstet Gynecol Reprod Biol X. 2019 Jul 10;4:100084. doi: 10.1016/j.eurox.2019.100084. eCollection 2019 Oct.
9
RAS/TP53 Co-mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease.RAS/TP53 共突变与结直肠肝转移和肝外疾病同时切除后的生存恶化相关。
Ann Surg. 2022 Aug 1;276(2):357-362. doi: 10.1097/SLA.0000000000004672. Epub 2020 Dec 18.
10
[Diagnosis, treatment and prognosis of uterine serous carcinoma].子宫浆液性癌的诊断、治疗与预后
Zhonghua Fu Chan Ke Za Zhi. 2020 Dec 25;55(12):848-856. doi: 10.3760/cma.j.cn112141-20200716-00580.

引用本文的文献

1
Onvansertib inhibits cell proliferation and increases sensitivity to paclitaxel in uterine serous cancer cells.奥万塞替布抑制子宫浆液性癌细胞的增殖并增加其对紫杉醇的敏感性。
Am J Cancer Res. 2025 Apr 15;15(4):1719-1732. doi: 10.62347/LIZG3616. eCollection 2025.

本文引用的文献

1
TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives.TCGA 子宫内膜癌分子预后分组:当前认识与未来展望。
Int J Mol Sci. 2022 Oct 2;23(19):11684. doi: 10.3390/ijms231911684.
2
Targeting ARID1A mutations in cancer.靶向 ARID1A 突变治疗癌症。
Cancer Treat Rev. 2021 Nov;100:102287. doi: 10.1016/j.ctrv.2021.102287. Epub 2021 Sep 6.
3
Endometrial cancer from early to advanced-stage disease: an update for radiologists.子宫内膜癌:从早期到晚期疾病——放射科医生的最新知识更新
Abdom Radiol (NY). 2021 Nov;46(11):5325-5336. doi: 10.1007/s00261-021-03220-7. Epub 2021 Jul 23.
4
Uterine serous carcinoma: key advances and novel treatment approaches.子宫浆液性癌:关键进展和新的治疗方法。
Int J Gynecol Cancer. 2021 Aug;31(8):1165-1174. doi: 10.1136/ijgc-2021-002753. Epub 2021 Jul 1.
5
A 4-gene signature predicts prognosis of uterine serous carcinoma.一个四基因标志物可预测子宫浆液性癌的预后。
BMC Cancer. 2021 Feb 12;21(1):154. doi: 10.1186/s12885-021-07834-4.
6
Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma.子宫内膜癌中鉴定出的致癌驱动基因突变的临床相关性。
Transl Oncol. 2021 Mar;14(3):101010. doi: 10.1016/j.tranon.2021.101010. Epub 2021 Jan 12.
7
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
8
Endometrial Cancer.子宫内膜癌
N Engl J Med. 2020 Nov 19;383(21):2053-2064. doi: 10.1056/NEJMra1514010.
9
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming.子宫内膜中 ARID1A 的失活通过转录重编程与子宫内膜样肿瘤发生相关。
Nat Commun. 2020 Jun 1;11(1):2717. doi: 10.1038/s41467-020-16416-0.
10
Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.肌肉浸润性尿路上皮癌:突变状态与转移模式和生存的关系。
Radiology. 2020 Jun;295(3):572-580. doi: 10.1148/radiol.2020191770. Epub 2020 Mar 31.